Spiration Inc. Obtains $26,900,000 Series E Financing

  • Feed Type
  • Date
    1/6/2004
  • Company Name
    Spiration Inc.
  • Mailing Address
    6675 185th Avenue N.E. Redmond, WA 98052
  • Company Description
    Spiration Inc. designs, manufactures and markets innovative Medical Devices & Instruments for the treatment of lung disease, including lung cancer and chronic obstructive pulmonary disease (COPD), which together claim nearly 275,000 lives in the United States each year, according to the American Lung Association and the American Cancer Society.
  • Website
    http://www.spiration.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $26,900,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    The current round of financing will be used to prepare for the launch of the VALR(TM) Surgical System and will fund clinical trials for the company’s second product, the Intra-Bronchial Valve (IBV(TM)).
  • M&A Terms
  • Venture Investor
    Investor Growth Capital
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Guidant Corporation
  • Venture Investor
    Three Arch Partners
  • Venture Investor
    Versant Ventures
  • Venture Investor
    New Leaf Venture Partners
  • Venture Investor
    InterWest Partners

By posting a comment, you agree to our terms and conditions.